[Skip to Content]
[Skip to Content Landing]

Age Disparities Among Cancer Clinical Trial Participants

A 2019 study reported that cancer trial participants are a mean 6.5 years younger than the true cancer population treated in practice, especially in industry-funded trials and those testing a targeted therapy. The findings suggest the evidence base for cancer therapeutics is not applicable to the broader patient population. JAMA Oncology Editor Mary (Nora) Disis, MD, of the University of Washington in Seattle explains the significance of the findings to JAMA Medical News senior staff writer Jennifer Abbasi.

JN Learning™ from JAMA Network is your new home for CME and MOC from a source you trust. Earn AMA PRA Category 1 CME Credit™ from relevant articles, audio, and Clinical Challenge image quizzes, explore interactives and videos, and – depending on your specialty or state – have your MOC points automatically transferred to the relevant board. Learn more about CME

Name Your Search

Save Search

Lookup An Activity


My Saved Searches

You currently have no searches saved.

State Requirements